Improvement of health-related quality of life and adherence to treatment with calcipotriol-betamethasone dipropionate gel in patients with psoriasis vulgaris

Abstract

BACKGROUNDPsoriasis is a common, chronic, recurrent, immune-mediated disorder of the skin and joints. It can have a significant negative impact on the physical, emotional and psychosocial wellbeing of affected patients.OBJECTIVESTo measure improvement in health-related QoL (HRQoL) in Greek patients with psoriasis vulgaris after a month of treatment with calcipotriol-betamethasone dipropionate gel; and evaluate adherence to treatment parameters.METHODSThe study included 394 psoriasis vulgaris patients from 16 private dermatological practices in Greece, all treated with calcipotriol-betamethasone dipropionate gel. They were evaluated at the first visit and after 4 weeks. Moreover, they completed the Dermatology Life Quality Index (DLQI), while other data such as disease severity, subjective symptoms and adherence, were collected.RESULTSAt week 4, the DLQI median was reduced by 3.5 points from the baseline (p<0.001; baseline and week 4 median: 4.5 and 1.0 respectively). Pruritus and sleep disorders also improved (p<0.001). Furthermore, 90.1% of the subjects fully adhered to treatment, with a 97.1% mean level of compliance.CONCLUSIONSThe convincing clinical results, with a distinct improvement in HRQoL, plus the high level of adherence due to its advantageous physical properties, make the calcipotriol-betamethasone dipropionate gel formulation an important, effective and well-tolerated topical therapy to treat psoriasis.

Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy

“…Psoriasis is associated with impaired quality of life (QoL) to a degree comparable with that in diseases such as malignancy, heart disease and diabetes . Studies have shown that QoL improves after successful treatment of psoriasis with topical applications …”

“…28 Studies have shown that QoL improves after successful treatment of psoriasis with topical applications. 29,30 Assessment of severity Assessment of disease severity is the cornerstone of psoriatic management and many options are available for this purpose. They vary from generic (e.g.…”

Transcriptome Profiling Analyses in Psoriasis: A Dynamic Contribution of Keratinocytes to the Pathogenesis

“…Plaque, erythrodermic, pustular, inverse and guttate psoriasis are the diverse subtypes of psoriasis, according to the onset of the disease. Plaque psoriasis, also known as psoriasis vulgaris, is the most common clinical subtype, affecting about 90% of patients [ 2 , 3 ]. The lesions are well-defined papulosquamous scales characterized by the focal formation of erythematous, raised plaques that constantly shed scales derived from excessive growth of skin epithelial cells [ 4 ].…”

Itching at night: A review on reducing nocturnal pruritus in children

“…Cortisol levels tend to drop at night, which may play a role in nighttime exacerbation of pruritic symptoms . Although topical glucocorticoids exert antiinflammatory rather than antipruritic effects, they have been shown to improve sleep quality in children with nocturnal pruritus secondary to AD and in adults with nocturnal itching secondary to psoriasis …”